Total: £ 56.28
Published Date: 2026-05-15 | Pages: 102 | Tables: 94 | Pharma & Healthcare
The global Iptacopan Hydrochloride Capsules market was valued at US$ 188 million in 2025 and is anticipated to reach US$ 950 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Iptacopan Hydrochloride Capsules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Iptacopan Hydrochloride Capsules are an oral, highly selective factor B inhibitor that reduces immune damage to the kidneys and related tissues by selectively inhibiting the overactivation of the complement alternative pathway. They are mainly used for the treatment of complement-mediated renal diseases such as IgA nephropathy and C3 glomerulopathy. As the world’s first oral targeted complement inhibitor approved for IgA nephropathy, it features convenient administration, a clear mechanism of action, and high patient compliance. It can significantly reduce proteinuria, delay renal function decline, and provide a novel non-immunosuppressive therapeutic option for patients with complement-related kidney diseases.In 2025, global Iptacopan Hydrochloride Capsules production reached approximately 1.2 million bottles.
As the world’s first oral highly selective factor B inhibitor, Iptacopan Hydrochloride Capsules have established an important clinical position in the field of complement-mediated renal diseases by virtue of their unique mechanism of targeted inhibition of the complement alternative pathway. Its core advantages lie in convenient administration and high compliance, which can effectively reduce proteinuria and delay renal function decline, providing a novel non-immunosuppressive treatment option for patients with limited previous therapeutic choices, such as those with IgA nephropathy and C3 glomerulopathy.
In terms of market layout, the drug is originally researched and exclusively manufactured by Novartis, and has been approved for marketing in many major global markets. Meanwhile, it is simultaneously promoting indication expansion and medical insurance coverage in China, which has significantly improved its accessibility. In the competitive landscape, its oral dosage form differentiates it from traditional injectable complement inhibitors, giving it a first-mover advantage in the complement drug sector. Furthermore, ongoing clinical studies on a variety of complement-related diseases are continuously expanding its market potential and application scenarios. Overall, the drug is at a critical stage of penetration from core indications to multiple disease areas, with sufficient market growth momentum and broad prospects for future development.
This report delivers a comprehensive overview of the global Iptacopan Hydrochloride Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Iptacopan Hydrochloride Capsules. The Iptacopan Hydrochloride Capsules market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Iptacopan Hydrochloride Capsules market comprehensively. Regional market sizes by Type, by Application, by Combination Therapy, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Iptacopan Hydrochloride Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis Pharma
Segment by Type
14 capsules/box
56 capsules/box
Segment by Combination Therapy
Combined With Renin-Angiotensin-Aldosterone System Inhibitors
Combined With Corticosteroids
Segment by Sales Channels
Hospital
Retail
Online
by Application
Treatment Of IgA Nephropathy
Treatment Of C3 Glomerulopathy
Treatment Of Complement-Mediated Renal Diseases
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Combination Therapy, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Iptacopan Hydrochloride Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Iptacopan Hydrochloride Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Iptacopan Hydrochloride Capsules Market Overview
1.1 Product Definition
1.2 Iptacopan Hydrochloride Capsules by Type
1.2.1 Global Iptacopan Hydrochloride Capsules Market Value by Type: 2025 vs 2032
1.2.2 14 capsules/box
1.2.3 56 capsules/box
1.3 Iptacopan Hydrochloride Capsules by Combination Therapy
1.3.1 Global Iptacopan Hydrochloride Capsules Market Value by Combination Therapy: 2025 vs 2032
1.3.2 Combined With Renin-Angiotensin-Aldosterone System Inhibitors
1.3.3 Combined With Corticosteroids
1.4 Iptacopan Hydrochloride Capsules by Sales Channels
1.4.1 Global Iptacopan Hydrochloride Capsules Market Value by Sales Channels: 2025 vs 2032
1.4.2 Hospital
1.4.3 Retail
1.4.4 Online
1.5 Iptacopan Hydrochloride Capsules by Application
1.5.1 Global Iptacopan Hydrochloride Capsules Market Value by Application: 2025 vs 2032
1.5.2 Treatment Of IgA Nephropathy
1.5.3 Treatment Of C3 Glomerulopathy
1.5.4 Treatment Of Complement-Mediated Renal Diseases
1.5.5 Others
1.6 Global Iptacopan Hydrochloride Capsules Market Size Estimates and Forecasts
1.6.1 Global Iptacopan Hydrochloride Capsules Revenue 2021–2032
1.6.2 Global Iptacopan Hydrochloride Capsules Sales 2021–2032
1.6.3 Global Iptacopan Hydrochloride Capsules Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Iptacopan Hydrochloride Capsules Market Competition by Manufacturers
2.1 Global Iptacopan Hydrochloride Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Iptacopan Hydrochloride Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Iptacopan Hydrochloride Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Iptacopan Hydrochloride Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Date of Entry into the Industry
2.8 Global Iptacopan Hydrochloride Capsules Market Competitive Situation and Trends
2.8.1 Global Iptacopan Hydrochloride Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Iptacopan Hydrochloride Capsules Players Market Share by Revenue
2.8.3 Global Iptacopan Hydrochloride Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Iptacopan Hydrochloride Capsules Market Scenario by Region
3.1 Global Iptacopan Hydrochloride Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Iptacopan Hydrochloride Capsules Sales by Region: 2021–2032
3.2.1 Global Iptacopan Hydrochloride Capsules Sales by Region: 2021–2026
3.2.2 Global Iptacopan Hydrochloride Capsules Sales by Region: 2027–2032
3.3 Global Iptacopan Hydrochloride Capsules Revenue by Region: 2021–2032
3.3.1 Global Iptacopan Hydrochloride Capsules Revenue by Region: 2021–2026
3.3.2 Global Iptacopan Hydrochloride Capsules Revenue by Region: 2027–2032
3.4 North America Iptacopan Hydrochloride Capsules Market Facts & Figures by Country
3.4.1 North America Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)
3.4.3 North America Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Iptacopan Hydrochloride Capsules Market Facts & Figures by Country
3.5.1 Europe Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)
3.5.3 Europe Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iptacopan Hydrochloride Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Iptacopan Hydrochloride Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Iptacopan Hydrochloride Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Iptacopan Hydrochloride Capsules Market Facts & Figures by Country
3.7.1 Latin America Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)
3.7.3 Latin America Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Iptacopan Hydrochloride Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Iptacopan Hydrochloride Capsules Sales by Type (2021–2032)
4.1.1 Global Iptacopan Hydrochloride Capsules Sales by Type (2021–2026)
4.1.2 Global Iptacopan Hydrochloride Capsules Sales by Type (2027–2032)
4.1.3 Global Iptacopan Hydrochloride Capsules Sales Market Share by Type (2021–2032)
4.2 Global Iptacopan Hydrochloride Capsules Revenue by Type (2021–2032)
4.2.1 Global Iptacopan Hydrochloride Capsules Revenue by Type (2021–2026)
4.2.2 Global Iptacopan Hydrochloride Capsules Revenue by Type (2027–2032)
4.2.3 Global Iptacopan Hydrochloride Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Iptacopan Hydrochloride Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Iptacopan Hydrochloride Capsules Sales by Application (2021–2032)
5.1.1 Global Iptacopan Hydrochloride Capsules Sales by Application (2021–2026)
5.1.2 Global Iptacopan Hydrochloride Capsules Sales by Application (2027–2032)
5.1.3 Global Iptacopan Hydrochloride Capsules Sales Market Share by Application (2021–2032)
5.2 Global Iptacopan Hydrochloride Capsules Revenue by Application (2021–2032)
5.2.1 Global Iptacopan Hydrochloride Capsules Revenue by Application (2021–2026)
5.2.2 Global Iptacopan Hydrochloride Capsules Revenue by Application (2027–2032)
5.2.3 Global Iptacopan Hydrochloride Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Iptacopan Hydrochloride Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis Pharma
6.1.1 Novartis Pharma Company Information
6.1.2 Novartis Pharma Description and Business Overview
6.1.3 Novartis Pharma Iptacopan Hydrochloride Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis Pharma Iptacopan Hydrochloride Capsules Product Portfolio
6.1.5 Novartis Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iptacopan Hydrochloride Capsules Industry Chain Analysis
7.2 Iptacopan Hydrochloride Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iptacopan Hydrochloride Capsules Production Mode & Process Analysis
7.4 Iptacopan Hydrochloride Capsules Sales and Marketing
7.4.1 Iptacopan Hydrochloride Capsules Sales Channels
7.4.2 Iptacopan Hydrochloride Capsules Distributors
7.5 Iptacopan Hydrochloride Capsules Customer Analysis
8 Iptacopan Hydrochloride Capsules Market Dynamics
8.1 Iptacopan Hydrochloride Capsules Industry Trends
8.2 Iptacopan Hydrochloride Capsules Market Drivers
8.3 Iptacopan Hydrochloride Capsules Market Challenges
8.4 Iptacopan Hydrochloride Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Iptacopan Hydrochloride Capsules Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Iptacopan Hydrochloride Capsules Market Value by Combination Therapy (US$ Million), 2025 vs 2032
Table 3. Global Iptacopan Hydrochloride Capsules Market Value by Sales Channels (US$ Million), 2025 vs 2032
Table 4. Global Iptacopan Hydrochloride Capsules Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Iptacopan Hydrochloride Capsules Market Competitive Situation by Manufacturers in 2025
Table 6. Global Iptacopan Hydrochloride Capsules Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Iptacopan Hydrochloride Capsules Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Iptacopan Hydrochloride Capsules Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Iptacopan Hydrochloride Capsules Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Iptacopan Hydrochloride Capsules, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Product Types and Applications
Table 14. Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Iptacopan Hydrochloride Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Iptacopan Hydrochloride Capsules Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Iptacopan Hydrochloride Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Iptacopan Hydrochloride Capsules Sales by Region (Units), 2021–2026
Table 20. Global Iptacopan Hydrochloride Capsules Sales Market Share by Region (2021–2026)
Table 21. Global Iptacopan Hydrochloride Capsules Sales by Region (Units), 2027–2032
Table 22. Global Iptacopan Hydrochloride Capsules Sales Market Share by Region (2027–2032)
Table 23. Global Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2021–2026
Table 24. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Region (2021–2026)
Table 25. Global Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2027–2032
Table 26. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Region (2027–2032)
Table 27. North America Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026
Table 29. North America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032
Table 30. North America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026
Table 31. North America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026
Table 34. Europe Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032
Table 35. Europe Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Iptacopan Hydrochloride Capsules Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Iptacopan Hydrochloride Capsules Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026
Table 44. Latin America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032
Table 45. Latin America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032
Table 52. Global Iptacopan Hydrochloride Capsules Sales (Units) by Type (2021–2026)
Table 53. Global Iptacopan Hydrochloride Capsules Sales (Units) by Type (2027–2032)
Table 54. Global Iptacopan Hydrochloride Capsules Sales Market Share by Type (2021–2026)
Table 55. Global Iptacopan Hydrochloride Capsules Sales Market Share by Type (2027–2032)
Table 56. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Type (2021–2026)
Table 59. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Type (2027–2032)
Table 60. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Type (2021–2026)
Table 61. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Type (2027–2032)
Table 62. Global Iptacopan Hydrochloride Capsules Sales (Units) by Application (2021–2026)
Table 63. Global Iptacopan Hydrochloride Capsules Sales (Units) by Application (2027–2032)
Table 64. Global Iptacopan Hydrochloride Capsules Sales Market Share by Application (2021–2026)
Table 65. Global Iptacopan Hydrochloride Capsules Sales Market Share by Application (2027–2032)
Table 66. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Application (2021–2026)
Table 69. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Application (2027–2032)
Table 70. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Application (2021–2026)
Table 71. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Application (2027–2032)
Table 72. Novartis Pharma Company Information
Table 73. Novartis Pharma Description and Business Overview
Table 74. Novartis Pharma Iptacopan Hydrochloride Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Novartis Pharma Iptacopan Hydrochloride Capsules Product
Table 76. Novartis Pharma Recent Developments/Updates
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Iptacopan Hydrochloride Capsules Distributors List
Table 80. Iptacopan Hydrochloride Capsules Customers List
Table 81. Iptacopan Hydrochloride Capsules Market Trends
Table 82. Iptacopan Hydrochloride Capsules Market Drivers
Table 83. Iptacopan Hydrochloride Capsules Market Challenges
Table 84. Iptacopan Hydrochloride Capsules Market Restraints
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Authors List of This Report
List of Figures
Figure 1. Product Picture of Iptacopan Hydrochloride Capsules
Figure 2. Global Iptacopan Hydrochloride Capsules Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Iptacopan Hydrochloride Capsules Market Share by Type: 2025 & 2032
Figure 4. 14 capsules/box Product Picture
Figure 5. 56 capsules/box Product Picture
Figure 6. Global Iptacopan Hydrochloride Capsules Market Value by Combination Therapy (US$ Million), 2021–2032
Figure 7. Global Iptacopan Hydrochloride Capsules Market Share by Combination Therapy: 2025 vs 2032
Figure 8. Combined With Renin-Angiotensin-Aldosterone System Inhibitors Product Picture
Figure 9. Combined With Corticosteroids Product Picture
Figure 10. Global Iptacopan Hydrochloride Capsules Market Value by Sales Channels (US$ Million), 2021–2032
Figure 11. Global Iptacopan Hydrochloride Capsules Market Share by Sales Channels: 2025 vs 2032
Figure 12. Hospital Product Picture
Figure 13. Retail Product Picture
Figure 14. Online Product Picture
Figure 15. Global Iptacopan Hydrochloride Capsules Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Iptacopan Hydrochloride Capsules Market Share by Application: 2025 & 2032
Figure 17. Treatment Of IgA Nephropathy
Figure 18. Treatment Of C3 Glomerulopathy
Figure 19. Treatment Of Complement-Mediated Renal Diseases
Figure 20. Others
Figure 21. Global Iptacopan Hydrochloride Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Iptacopan Hydrochloride Capsules Market Size (US$ Million), 2021–2032
Figure 23. Global Iptacopan Hydrochloride Capsules Sales (Units), 2021–2032
Figure 24. Global Iptacopan Hydrochloride Capsules Average Price (US$/Unit), 2021–2032
Figure 25. Iptacopan Hydrochloride Capsules Report Years Considered
Figure 26. Iptacopan Hydrochloride Capsules Sales Share by Manufacturers in 2025
Figure 27. Global Iptacopan Hydrochloride Capsules Revenue Share by Manufacturers in 2025
Figure 28. Top 5 and Top 10 Global Iptacopan Hydrochloride Capsules Players: Market Share by Revenue in Iptacopan Hydrochloride Capsules in 2025
Figure 29. Iptacopan Hydrochloride Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Global Iptacopan Hydrochloride Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 31. North America Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)
Figure 32. North America Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)
Figure 33. United States Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)
Figure 36. Europe Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)
Figure 37. Germany Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. France Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. U.K. Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Asia Pacific Iptacopan Hydrochloride Capsules Sales Market Share by Region (2021–2032)
Figure 43. Asia Pacific Iptacopan Hydrochloride Capsules Revenue Market Share by Region (2021–2032)
Figure 44. China Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Japan Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. South Korea Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. India Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Australia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. China Taiwan Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Southeast Asia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Latin America Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)
Figure 52. Latin America Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)
Figure 53. Mexico Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Brazil Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Argentina Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Colombia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Middle East and Africa Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)
Figure 58. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)
Figure 59. Turkey Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Saudi Arabia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. UAE Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Global Sales Market Share of Iptacopan Hydrochloride Capsules by Type (2021–2032)
Figure 63. Global Revenue Market Share of Iptacopan Hydrochloride Capsules by Type (2021–2032)
Figure 64. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Type (2021–2032)
Figure 65. Global Sales Market Share of Iptacopan Hydrochloride Capsules by Application (2021–2032)
Figure 66. Global Revenue Market Share of Iptacopan Hydrochloride Capsules by Application (2021–2032)
Figure 67. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Application (2021–2032)
Figure 68. Iptacopan Hydrochloride Capsules Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed